Phase I results of Genta's lead antisense drug combined with chemotherapy reported at ASCO May 30, 2000
Onconase may be associated with survival benefit versus doxorubicin in certain UMM patients May 30, 2000
Aronex reports clinical results for Atragen in APL and renal cell cancer at ASCO meeting May 29, 2000